According to Zealand Pharma's latest financial reports the company's current EPS (TTM) is -$2.75. In 2022 the company made an earnings per share (EPS) of -$3.72 a decrease over its 2021 EPS that were of -$3.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.75 | -26.12% |
2022 | -$3.72 | 0.04% |
2021 | -$3.72 | 6.81% |
2020 | -$3.48 | 34.04% |
2019 | -$2.60 | -188.77% |
2018 | $2.93 | -289.29% |
2017 | -$1.55 | 58.29% |
2016 | -$0.98 | 29.66% |
2015 | -$0.75 | 49.34% |
2014 | -$0.50 | -64.92% |
2013 | -$1.44 | -605.09% |
2012 | $0.28 | -344.12% |
2011 | -$0.12 | -90.48% |
2010 | -$1.22 |